CN1814112A - Collateral-flow-activating pain-relieving medicine of Rhizoma cyperi - Google Patents
Collateral-flow-activating pain-relieving medicine of Rhizoma cyperi Download PDFInfo
- Publication number
- CN1814112A CN1814112A CN 200510128009 CN200510128009A CN1814112A CN 1814112 A CN1814112 A CN 1814112A CN 200510128009 CN200510128009 CN 200510128009 CN 200510128009 A CN200510128009 A CN 200510128009A CN 1814112 A CN1814112 A CN 1814112A
- Authority
- CN
- China
- Prior art keywords
- herba
- parts
- rhizoma cyperi
- medicine
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a meridian-activating pain-stopping Nutgrass Galingale Rhizome medicine, prepared of Nutgrass Galingale Rhizome, Laoshujiaoji, Inulacappa DC, Blumea laciniata (Roxb.) DC, Forrest Silkvine Stem or Root, Clematis huchouensis Tamura ( Root and Herb ), Tetrastigma delavayi Gagn, Yiwenqian, Saussurea japonica (Thunb.)DC, Murraya exotica L and alcohol in a certain weight proportion; these drugs cooperate to be able to effective treat rheumatic muscles and bones aches, traumatic injury, traumatic gall, soft tissue injury, rheumatic arthritis, atrophic arthritis, rheumatic waist and leg arthralgia, and it is a meridian-activating pain-stopping medicine having characters of low cost, reasonable formula, fast curing, good curative effect, etc.
Description
Technical field:
The present invention relates to a kind of Rhizoma Cyperi activating collaterals to relieve pain medicine.
Background technology:
The traumatic injury disease is a kind of incidental common disease, people accidentally will damage when working, be subjected to ailing the torment deeply, the various external use medicament for traumatic injury of Xiao Shouing are also many in the market, slight illness for the treatment traumatic injury has played certain therapeutic effect really, but does not also have a kind of activating collaterals to relieve pain specific drug of real rapid healing traumatic injury.
Summary of the invention:
The inventor is at above-mentioned weak point, at an urgent demand of suffering from traumatic injury person, need have a kind of quick and convenient, eutherapeutic medicine for external use; The inventor is through research repeatedly, and by clinical trial, checking repeatedly, developed finally a kind of with low cost, prescription rationally, preparation is simple, very easy to use, cures soon eutherapeutic activating collaterals to relieve pain medicine.
Purpose of the present invention just provides a kind of Rhizoma Cyperi activating collaterals to relieve pain medicine.
Choice of drug Rhizoma Cyperi of the present invention, Herba Epaltis Australis, Herba Inulae cappae, the Herba Blumeae Laciniatae, Caulis et Radix Periplocae Forrestii, Herba Clematidis Huchouensis, Tetrastigma delavayi Gagn, Radix Stephaniae Gracilifoliae, Herba Saussuseae Japonicae, Folium Et Cacumen Murrayae, ethanol (concentration is 70%) are formed; Wherein select Rhizoma Cyperi for use: have diffusing blood blood stasis removing; Control traumatic injury.Select Herba Epaltis Australis for use: have stasis-dispelling and pain-killing; Control traumatic injury.Select Herba Inulae cappae for use: have expelling wind and removing dampness; The dispelling the wind and dampness pathogens arthralgia, lumbago and skelalgia.Select the Herba Blumeae Laciniatae for use: have wind-damp dispelling, the meridian dredging; The dispelling the wind and dampness pathogens arthralgia pain, rheumatic arthritis, traumatic injury.Select Caulis et Radix Periplocae Forrestii for use: have the meridian dredging, expelling wind and removing dampness, anti inflammatory blood quickening; Control traumatic injury, rheumatic arthritis.Select Herba Clematidis Huchouensis for use: have promoting blood circulation to remove blood stasis, expelling wind and removing dampness; Treating rheumatic arthritis, traumatic injury.Select Tetrastigma delavayi Gagn for use: have removing blood stasis and activating blood flow, expelling wind and removing dampness; Dispelling the wind and dampness pathogens pain, traumatic injury.Select Radix Stephaniae Gracilifoliae for use: have expelling wind and removing dampness; Treating rheumatic arthritis.Select Herba Saussuseae Japonicae for use: have expelling wind and activating blood circulation; The dispelling the wind and dampness pathogens arthralgia pain, traumatic injury, rheumatic arthralgia.Select Folium Et Cacumen Murrayae for use: have promoting flow of QI and blood, expelling wind and removing dampness; Control treating swelling and pain by traumatic injury.Make these drug regimens to such an extent that the effect of each medicine produces collaborative effect, thus can realize effectively treating rheumatism bones and muscles pain, traumatic injury, treating swelling and pain by traumatic injury, sprain swell and ache, soft tissue contusion, rheumatism, rheumatoid arthritis, rheumatism waist leg joint pain, blood stasis swell and ache, muscles and bones is sprained pain, bones and muscles pain, osteopatia sprain, traumatic injury sprain and contusion are hindered curative effect of disease is fine.
The consumption of drug component of the present invention also is to carry out a large amount of solid lines through the inventor to grope to sum up and draw, and each amounts of components is for all to have better therapeutic effect in the following weight parts scope; It is made up of the component of following parts by weight:
Rhizoma Cyperi 1-12 part, Herba Epaltis Australis 1-12 part, Herba Inulae cappae 1-9 part, Herba Blumeae Laciniatae 1-12 part, Caulis et Radix Periplocae Forrestii 1-12 part, Herba Clematidis Huchouensis 1-12 part, Tetrastigma delavayi Gagn 1-9 part, Radix Stephaniae Gracilifoliae 1-9 part, Herba Saussuseae Japonicae 1-12 part, Folium Et Cacumen Murrayae 1-9 part, ethanol (70%) 40-432 part.
Optimization formula of the present invention is:
9 parts of Rhizoma Cyperis, 9 parts of Herba Epaltis Australiss, 6 parts of Herba Inulae cappaes, 9 parts of the Herba Blumeae Laciniataes, 9 parts of Caulis et Radix Periplocae Forrestiis, 9 parts of Herba Clematidis Huchouensiss, 6 parts of Tetrastigma delavayi Gagn, 6 parts of Radix Stephaniae Gracilifoliaes, 9 parts of Herba Saussuseae Japonicaes, 6 parts of Folium Et Cacumen Murrayae, (70%) 234 part of ethanol.
A kind of Rhizoma Cyperi activating collaterals to relieve pain medicine of the present invention has the effect of relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation to remove blood stasis, Repercusion analgesia; Be a kind of with low cost, prescription rationally, preparation is simple, very easy to use, cure fast, eutherapeutic activating collaterals to relieve pain medicine.Rhizoma Cyperi medicine for external use of the present invention was once done a large amount of clinical trials in early stage, give on the patient treatment case surplus in the of tens example time, comprise be used for the treatment of rheumatism bones and muscles pain, traumatic injury, treating swelling and pain by traumatic injury, sprain swell and ache, soft tissue contusion, rheumatism, rheumatoid arthritis, rheumatism waist leg joint pain, blood stasis swell and ache, muscles and bones is sprained pain, bones and muscles pain, osteopatia sprain, traumatic injury sprain and contusion are hindered curative effect of disease is fine.
Using method:
This medicine is a medicine for external use, oral administration not, and anemia of pregnant woman, blood deficiency do not have the stasis of blood person of wound forbidding.At first the affected part is cleaned with hot water, will gently be used in the affected part, gently put the affected part on the skin heating for good with the palm of the hand, every day 3-6 time with the drenched medicinal liquid of absorbent cotton.
The specific embodiment:
Describe embodiments of the invention below in detail:
Embodiment 1:
A kind of Rhizoma Cyperi activating collaterals to relieve pain medicine provided by the present invention is made up of the component of following parts by weight; Rhizoma Cyperi 1-12 part, Herba Epaltis Australis 1-12 part, Herba Inulae cappae 1-9 part, Herba Blumeae Laciniatae 1-12 part, Caulis et Radix Periplocae Forrestii 1-12 part, Herba Clematidis Huchouensis 1-12 part, Tetrastigma delavayi Gagn 1-9 part, Radix Stephaniae Gracilifoliae 1-9 part, Herba Saussuseae Japonicae 1-12 part, Folium Et Cacumen Murrayae 1-9 part, ethanol (70%) 40-432 part.
Embodiment 2:
Optimization formula of the present invention is:
9 parts of Rhizoma Cyperis, 9 parts of Herba Epaltis Australiss, 6 parts of Herba Inulae cappaes, 9 parts of the Herba Blumeae Laciniataes, 9 parts of Caulis et Radix Periplocae Forrestiis, 9 parts of Herba Clematidis Huchouensiss, 6 parts of Tetrastigma delavayi Gagn, 6 parts of Radix Stephaniae Gracilifoliaes, 9 parts of Herba Saussuseae Japonicaes, 6 parts of Folium Et Cacumen Murrayae, (70%) 234 part of ethanol.
Preparation method of the present invention is: at first with above-mentioned Rhizoma Cyperi, Herba Epaltis Australis, Herba Inulae cappae, the Herba Blumeae Laciniatae, Caulis et Radix Periplocae Forrestii, Herba Clematidis Huchouensis, Tetrastigma delavayi Gagn, Radix Stephaniae Gracilifoliae, Herba Saussuseae Japonicae, Folium Et Cacumen Murrayae, the single short fragment that is cut into respectively, each single short fragment that is cut into is mixed in proportion and is placed at together in the container, and after allocating ethanol into and mixing evenly with seal of vessel, soaked 7-15 days or produce according to the modern Chinese medicine processing technology; The mixture solution that soaks packed into according to the required metering of client after treatment get product in the bottle.
Claims (3)
1, a kind of Rhizoma Cyperi activating collaterals to relieve pain medicine is characterized in that: Rhizoma Cyperi, Herba Epaltis Australis, Herba Inulae cappae, the Herba Blumeae Laciniatae, Caulis et Radix Periplocae Forrestii, Herba Clematidis Huchouensis, Tetrastigma delavayi Gagn, Radix Stephaniae Gracilifoliae, Herba Saussuseae Japonicae, Folium Et Cacumen Murrayae, ethanol (70%).
2, a kind of Rhizoma Cyperi activating collaterals to relieve pain medicine according to claim 1, it is characterized in that: the component by following parts by weight is formed; Rhizoma Cyperi 1-12 part, Herba Epaltis Australis 1-12 part, Herba Inulae cappae 1-9 part, Herba Blumeae Laciniatae 1-12 part, Caulis et Radix Periplocae Forrestii 1-12 part, Herba Clematidis Huchouensis 1-12 part, Tetrastigma delavayi Gagn 1-9 part, Radix Stephaniae Gracilifoliae 1-9 part, Herba Saussuseae Japonicae 1-12 part, Folium Et Cacumen Murrayae 1-9 part, ethanol 40-432 part.
3, a kind of Rhizoma Cyperi activating collaterals to relieve pain medicine according to claim 1, it is characterized in that: the component by following parts by weight is formed; 9 parts of Rhizoma Cyperis, 9 parts of Herba Epaltis Australiss, 6 parts of Herba Inulae cappaes, 9 parts of the Herba Blumeae Laciniataes, 9 parts of Caulis et Radix Periplocae Forrestiis, 9 parts of Herba Clematidis Huchouensiss, 6 parts of Tetrastigma delavayi Gagn, 6 parts of Radix Stephaniae Gracilifoliaes, 9 parts of Herba Saussuseae Japonicaes, 6 parts of Folium Et Cacumen Murrayae, 234 parts of ethanol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510128009 CN1814112A (en) | 2005-11-22 | 2005-11-22 | Collateral-flow-activating pain-relieving medicine of Rhizoma cyperi |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510128009 CN1814112A (en) | 2005-11-22 | 2005-11-22 | Collateral-flow-activating pain-relieving medicine of Rhizoma cyperi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1814112A true CN1814112A (en) | 2006-08-09 |
Family
ID=36906544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510128009 Pending CN1814112A (en) | 2005-11-22 | 2005-11-22 | Collateral-flow-activating pain-relieving medicine of Rhizoma cyperi |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1814112A (en) |
-
2005
- 2005-11-22 CN CN 200510128009 patent/CN1814112A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1814180A (en) | Collateral-flow-activating pain-relieving medicine of Herba Paederiae | |
| CN1814010A (en) | Japanese supplejack collateral-flow-activating pain-relieving medicine | |
| CN1813952A (en) | Medicine of yellow cinnamon root for activating collaterals | |
| CN1742816A (en) | Wujiaofeng root external-use medicine | |
| CN1814066A (en) | Collateral-flow-activating pain-relieving medicine of caulis et Folium Trachelospermi | |
| CN1814069A (en) | Collateral-flow-activating pain-relieving medicine of Herba Antenori Filliformis root | |
| CN1814065A (en) | Collateral-flow-activating pain-relieving medicine of Herba Tetrastigmae Yunnanensis | |
| CN1814067A (en) | Collateral-flow-activating pain-relieving medicine of caulis parthenocissi laetevirentis | |
| CN100417405C (en) | Collateral-flow-activating pain-relieving medicine of Ramulus et Folium Vaccinii | |
| CN1813898A (en) | External-use medicine of hayberry bark for traumatic injury and activating collaterals | |
| CN1814103A (en) | Collateral-flow-activating pain-relieving medicine of Radix Ardisiae crenatae | |
| CN1813930A (en) | Chinese medicine of securidaca inappendiculata hassk for activating collaterals and stopping pain | |
| CN1814112A (en) | Collateral-flow-activating pain-relieving medicine of Rhizoma cyperi | |
| CN1814140A (en) | Collateral-flow-activating pain-relieving medicine of Munronia Henryi | |
| CN100462087C (en) | Barban drug for activating collaterals and stopping pain | |
| CN100462090C (en) | Collateral-flow-activating pain-relieving medicine of Radix cyathulae | |
| CN1762479A (en) | Externally applied medicine of stahlianthus involucratus | |
| CN100361687C (en) | Collateral-flow-activating pain-relieving medicine of Radix Asteris Scabri | |
| CN1814068A (en) | Collateral-flow-activating pain-relieving medicine of Herba sarcandrae | |
| CN1813951A (en) | Medicine of acuonitum brachaypodum diels for activating collaterals and stopping pain | |
| CN1814087A (en) | Wind-repellent collateral-activating pain-relieving medicine of Herba clemati dis Intricatae | |
| CN1742815A (en) | External-use medicine of lysimachia root | |
| CN1742907A (en) | External-use medicine of Radix celastri orbiculati | |
| CN1814088A (en) | Wind-repellent collateral-activating pain-relieving medicine of Radix Rhodiolae | |
| CN1814160A (en) | Wind-repellent collateral-flow-activating pain-relieving method of Herba Androsacis Umbellatae |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |